Beta-Hemolytic Streptococcal Infections In Children

Abstract
In our continuing investigations of therapeutic agents for β-hemolytic streptococcal infections in children, four oral antibiotics were tested between Dec 15, 1959, and March 15, 1960. They were: buffered potassium penicillin G (Pentids), potassium phenethecillin (Syncillin, and Chemipen), tetracycline phosphate complex (Sumycin), and demethylchlortetracycline (Declomycin). Two of these, phenethecillin and demethylchlortetracycline, were then relatively recent additions to the antibiotic field. It was hoped to determine by therapeutic trial whether these two newer products were superior to the older analogues, sodium penicillin G and tetracycline complex, in the treatment of streptococcal infections in children. We also wished to determine whether there was any evidence that tetracycline resistant streptococci had appeared in our community. Such resistance had been described by Mogabgab and Pelon in 1958,6and since this study by Kuharic, Roberts, and Kirby (1960)7and McCormack, Kaye, and Hook in 1962.4In addition we conducted a small therapeutic

This publication has 4 references indexed in Scilit: